Effect of intracranial bleeds on the health and quality of life of boys with hemophilia

Journal of Pediatrics

Volumn 144, Issue 4, 2004, Pages 490-495

  Revel Vilk, Shoshana ^b   Golomb, Meredith R ^b   Achonu, Camille ^b   Stain, Ann Marie ^b   Armstrong, Derek ^b   Barnes, Marcia A ^b   Anderson, Peter ^b   Logan, William J ^b   Sung, Lillian ^b   McNeely, Michael ^b   Blanchette, Victor ^a   Feldman, Brian M ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRAIN HEMORRHAGE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; HEMOPHILIA; HOUSEHOLD; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVOUS SYSTEM FUNCTION; NEUROLOGIC EXAMINATION; OUTCOMES RESEARCH; POPULATION RESEARCH; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE; SCORING SYSTEM; SEX DIFFERENCE;

EID: 11144354682     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2003.12.016     Document Type: Article

References (23)

1. Klinge J, Auberger K, Auerswald G, Brackmann HH, Mauz-Korholz C, Kreuz W. Prevalence and outcome of intracranial haemorrhage in haemophiliacs - a survey of the paediatric group of the German Society of Thrombosis and Haemostasis (GTH). Eur J Pediatr 1999;158(suppl 3):S162-S165.
2. Kulkarni R, Lusher JM. Intracranial and extracranial hemorrhages in newborns with hemophilia: a review of the literature. J Pediatr Hematol Oncol 1999;21:289-95.
3. de Tezanos Pinto M, Fernandez J, Perez Bianco PR. Update of 156 episodes of central nervous system bleeding in hemophiliacs. Haemostasis 1992;22:259-67.
4. Nelson MD Jr, Maeder MA, Usner D, Mitchell WG, Fenstermacher MJ, Wilson DA, et al. Prevalence and incidence of intracranial haemorrhage in a population of children with haemophilia. The Hemophilia Growth and Development Study. Haemophilia 1999;5:306-12.
5. Nuss R, Soucie JM, Evatt B, Hemophilia Surveillance System Project Investigators. Changes in the occurrence of and risk factors for hemophilia-associated intracranial hemorrhage. Am J Hematol 2001;68:37-42.
6. Fischer K, van der Bom JG, Mauser-Bunschoten EP, Roosendaal G, Prejs R, de Kleijn P, et al. The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia. Blood 2002;99: 2337-41.
7. Martinowitz U, Heim M, Tadmor R, Eldor A, Rider I, Findler G, et al. Intracranial hemorrhage in patients with hemophilia. Neurosurgery 1986;18:538-41.
8. Braveman P, Cubbin C, Marchi K, Egerter S, Chavez G. Measuring socioeconomic status/position in studies of racial/ethnic disparities: maternal and infant health. Public Health Rep 2001;116:449-63.
9. deVeber GA, MacGregor D, Curits R, Mayank S. Neurologic outcome in survivors of childhood arterial ischemic stroke and sinovenous thrombosis. J Child Neurol 2000;15:316-24.
10. Young NL, Williams JI, Yoshida KK, Wright JG. Measurement properties of the Activities Scale for Kids. J Clin Epidemiol 2000;53:125-37.
11. Singh G, Athreya BH, Fries JF, Goldsmith DP. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 1994;12:1761-99.
12. Feldman BM, Grundland B, McCullough L, Wright V. Distinction of quality of life, health related quality of life, and health status in children referred for rheumatologic care. J Rheumatol 2000;27:226-33.
13. Usner DW, Donfield SM, Sirois PA, et al. Hemophilia morbidity, cognitive functioning, and academic achievement. J Pediatr 1998;133:782-7.
14. Wilson DA, Nelson MD Jr, Fenstermacher MJ, Bohan TP, Hopper KD, Tilton A, et al. Brain abnormalities in male children and adolescents with hemophilia: detection with MR imaging. The Hemophilia Growth and Development Study Group. Radiology 1992;185:553-8.
15. Dempster H, Porepa M, Young N, Feldman BM. The clinical meaning of functional outcome scores in children with juvenile arthritis. Arthritis Rheum 2001;44:1768-74.
16. Miners AH, Sabin CA, Tolley KH, Jenkinson C, Kind P, Lee CA. Assessing health-related quality-of-life in individuals with haemophilia. Haemophilia 1999;5:378-85.
17. Trippoli S, Vaiani M, Linari S, Longo G, Morfini M, Messori A. Multivariate analysis of factors influencing quality of life and utility in patients with haemophilia. Haematologica 2001;86:722-8.
18. Solovieva S. Clinical severity of disease, functional disability and health-related quality of life: three-year follow-up study of 150 Finnish patients with coagulation disorders. Haemophilia 2001;7:53-63.
19. de Joode EWP, van Meeteren NLU, van den Berg HM, de Kleijn P, Helders PJM. Validity of health status measurement scale 2 in individuals with severe haemophilia. Haemophilia 2001;7:190-7.
20. Naraine VS, Risebrough NA, Oh P, Blanchette VS, Lee S, Stain AM, et al. Health-related quality-of-life treatments for severe haemophilia: utility measurements using the Standard Gamble technique. Haemophilia 2002; 8:112-20.
21. Royal S, Schramm W, Berntrop E, Giangrande P, Gringeri A, Ludlam C, et al. Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients. Haemophilia 2002;8:44-50.
22. Fisher K, van der Bom JG, van den Berg HM. Health-related quality of life as outcome parameter in haemophilia treatment. Haemophilia 2003;9(suppl 1):75-82.
23. Schramm W, Berger K. Economics of prophylactic treatment. Haemophilia 2003;9(suppl 1):111-6.